SERPINA3 and neurodegenerative disease: SERPINA3 was also found to be significantly upregulated in the motor cortex of ALS patients [55] and expressed four-fold more in the MSA frontal cortex compared to controls [56], suggesting SERPINA3 involvement in other types of neurodegenerative diseases.